← Back to headlines
Nyxoah Reports Positive Safety and Efficacy Results from ACCCESS U.S. Study
The company announced that its pivotal ACCCESS clinical trial met primary safety and efficacy endpoints in patients with complete concentric collapse.
2 Sept, 20:05 — 2 Sept, 20:05
Related Stories
New Zealand Approves MDMA Prescription for PTSD Treatment
54m ago
UNICEF Report Reveals 20 Million Children Face Annual Online Sexual Exploitation
1h ago
Genetically Modified Pig Kidney Sustains Patient for Record Nine Months
2h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
6h ago